Study on biomarkers related to hypertension in Guangdong Province
Establishing Biobank in a Cohort Study for Hypertensive Patients in Guangdong Province(GDP Study)
This study is trying to see how certain blood markers are linked to health problems in people with high blood pressure in Guangdong Province.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 50000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Guangdong Provincial People's Hospital Academic / other |
| Locations | 2 sites (Guangzhou, Guangdong and 1 other locations) |
| Trial ID | NCT04212455 on ClinicalTrials.gov |
What this trial studies
This observational study aims to explore the relationship between biomarkers and adverse health outcomes in individuals diagnosed with hypertension. Participants aged 18 and older will provide whole blood samples and undergo physical examinations and surveys at baseline. The study will track the incidence of all-cause and cardiovascular mortality during follow-up to better understand the impact of these biomarkers. The research focuses on a diverse population within Guangdong Province, emphasizing the public health implications of hypertension.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older who have been diagnosed with hypertension.
Not a fit: Patients under 18 years old, those who cannot provide informed consent, and pregnant or lactating women may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved identification of high-risk patients and better management strategies for hypertension.
How similar studies have performed: Other studies have shown success in identifying biomarkers associated with hypertension, suggesting that this approach is promising and builds on existing knowledge.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * ≥18 years old * In accordance with the diagnosis of hypertension (including Blood pressure ≥140/90mmHg and/or taking antihypertensive drugs and/or self-reported hypertension) Exclusion Criteria: * \<18 years old * Unsigned informed consent * Pregnant Women and Lactation
Where this trial is running
Guangzhou, Guangdong and 1 other locations
- Guangdong Provincial People's Hospital — Guangzhou, Guangdong, China (Recruiting)
- Guangdong Cardiovascular Institute — Guangzhou, Guangdong, China (Recruiting)
Study contacts
- Study coordinator: Feng Ying-qing, PhD
- Email: 651792209@qq.com
- Phone: 86-2083827812
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.